EP Patent

EP4155314A1 — Neuroactive steroids, compositions, and uses thereof

Assigned to Sage Therapeutics Inc · Expires 2023-03-29 · 3y expired

What this patent protects

Described herein are neuroactive steroids of the Formula (I):or a pharmaceutically acceptable salt thereof; wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>a</sup>, G, X, Y, Z, and n are as defined herein. Such compounds are envisioned, in certain …

USPTO Abstract

Described herein are neuroactive steroids of the Formula (I):or a pharmaceutically acceptable salt thereof; wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>a</sup>, G, X, Y, Z, and n are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. Also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Drugs covered by this patent

Patent Metadata

Patent number
EP4155314A1
Jurisdiction
EP
Classification
—
Expires
2023-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.